4//SEC Filing
Kelly Leanne M. 4
Accession 0001104659-21-068835
CIK 0001824293other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:07 PM ET
Size
5.5 KB
Accession
0001104659-21-068835
Insider Transaction Report
Form 4
Kelly Leanne
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-05-14+70,000→ 70,000 totalExercise: $3.66Exp: 2031-05-14→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 12 equal quarterly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant.
Documents
Issuer
Vallon Pharmaceuticals, Inc.
CIK 0001824293
Entity typeother
Related Parties
1- filerCIK 0001398278
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:07 PM ET
- Size
- 5.5 KB